Back
ESC Professional Premium Access

Valsartan reduces arterial stiffness along with level of soluble ST2 independently of blood pressure changes

Session: Hypertension - Pharmacotherapy
Topic: Pharmacotherapy
Speaker: Doctor A. Tomasik (Zabrze, PL)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Andrzej Tomasik

The Medical University of Silesia, Zabrze (Poland)
0 follower

7 more presentations in this session

Intensive reduction of high normal blood pressures: PRINT-TAHA9 randomized clinical trial

Speaker: Associate Professor A. Attar (Shiraz, IR)

Access
Abstract
Slides
Thumbnail

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Speaker: Doctor M. Freeman (Boston, US)

Access
Abstract
Slides
Thumbnail

Differentiated approach to the treatment of uncomplicated hypertensive crisis

Speaker: Doctor M. Sadulloeva (Tashkent, UZ)

Access
Abstract
Slides
Thumbnail

Blockade of the renin-angiotensin system as a therapeutic target of NAFLD: results of an experimental model of hypercholesterolemia

Speaker: Professor D. Bertolim Precoma (Campina Grande do Sul, BR)

Access
Abstract
Slides
Thumbnail

Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study

Speaker: Doctor F. Goetzinger (Homburg, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Hypertension - Pharmacotherapy

Speakers: Doctor A. Tomasik, Associate Professor A. Attar, Doctor M. Freeman, Doctor M. Sadulloeva, Professor D. Bertolim Precoma...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb